Lung transplantation recipients with NAFLD

Advanced hepatic fibrosis and cirrhosis are absolute contraindications to lung transplantation. In a retrospective analysis of 150 transplanted patients, A. J. Trindade et al. (Brigham and Women’s Hospital/Harvard Medical School, and Vanderbilt University Medical Center, USA) aimed to determine if mild-moderate NAFLD contributes to increased adverse outcomes...
PUBLISHED IN: ERJ Open Res 2021

Commentary

Advanced hepatic fibrosis and cirrhosis are absolute contraindications to lung transplantation. In a retrospective analysis of 150 transplanted patients, A. J. Trindade et al. (Brigham and Women’s Hospital/Harvard Medical School, and Vanderbilt University Medical Center, USA) aimed to determine if mild-moderate NAFLD contributes to increased adverse outcomes post-lung transplantation.

Median index hospital-free days for patients with NAFLD were non-inferior to those without. Regarding secondary outcomes, both index hospitalisation and 1-year outcomes were non-inferior between patients with NAFLD and those with normal liver architecture. This study demonstrates that mild-moderate severity NAFLD may not be a contraindication to lung transplantation.

Share the article
Avatar photo

Dr. D. Beard

DR. D. BEARD is specialist of Nash Pathology

Articles: 191

Leave a Reply

Your email address will not be published. Required fields are marked *

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES